IoGyn
Women’s health: Boston Scientific nabs the rest of IoGyn for $65M
Medtech titan Boston Scientific (NYSE:BSX) announced today that it acquired IoGyn, maker of the Symphion system for removing intrauterine tissue, for $65 million, not including previous investments.